Free Daily Podcast Summary
GEN Podcasts: Daily Summaries Delivered
by Genetic Engineering & Biotechnology News (GEN)
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/pri
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 6 days ago41 min
Precision Automation Meets Biology
Episode 1: Precision Automation Meets Biology Central question: How can automation help scientists move faster without losing sight of the biology? This opening episode would introduce precision automation as the connective tissue across the Molecular Devices portfolio. Rather than defining automation simply as higher throughput, we would explore how purpose-built tools help biologists reduce repetitive work, control variability, improve consistency, and focus more of their time on scientific decisions. Potential discussion points: What “precision automation” means for a working biologist Why automation should adapt to the science — not force the science into a rigid process Where manual variability enters cell-based research The balance between speed, consistency, flexibility, and scientific control How purpose-built instruments, software, and expertise work together Why researchers may need different solutions at different points in their journeySpeaker: Matt Stoltz Moderator: Uduak Thomas Hosted on Acast. See acast.com/privacy for more information.
- Sep 9, 202617 min
Data Integrity as the Foundation for AI
Artificial intelligence is advancing quickly into laboratory operations, which is why thinking about the quality and integrity of the supporting data early on is important. In regulated environments, that means understanding where the data came from, how it changes, and how AI-generated insights or recommendations can be traced, reviewed, trusted, and ultimately defended.In this GEN podcast, LabVantage’s Gary Stimson digs into what it takes to build a data foundation for trustworthy AI. The discussion covers concepts like data lineage, traceability, explainability and governance, and the importance of audit-ready laboratory operations. It also looks at the role of intended use, ongoing monitoring, and human review in deploying AI responsibly. Hosted on Acast. See acast.com/privacy for more information.
- Aug 19, 202633 min
Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability
Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are creating new challenges for the industry.In this GEN Podcast – part 2 in a 3-part series -- a trio of experts from SK Pharmteco discuss how CDMOs are helping biopharma companies navigate critical areas including scale-up, technology transfer, advanced manufacturing, automation, sustainability, the emergence of AI, and supply chain reliability. The discussion explores practical strategies for improving development efficiency while supporting quality, scalability, and long-term commercial success.Guest SpeakersSteve Barr, PhD -- Head of Small Molecule Business Unit and VP Global Alliances, SK Pharmteco.Darryl Ratty -- Executive Director of Global ESG (Environmental, Social and Governance), SK Pharmteco.Bill Dubay -- VP, Global Research and Development, SK Pharmteco.Moderator:Kevin Davies, PhD, Editorial Director, GEN Hosted on Acast. See acast.com/privacy for more information.
- Jul 27, 202624 min
Beyond the Technology: AI Readiness in Regulated Laboratories
This episode establishes the broader context for AI adoption. Rather than focusing on AI tools themselves, the discussion explores what laboratories must have in place before AI can be applied responsibly. Key discussion areas include: Why fragmented workflows and disconnected systems limit AI effectiveness The importance of trusted, connected laboratory data Human-guided AI and human-in-the-loop governance Why compliance and auditability should be built into AI-enabled workflows from the outset Relevant reference to LabVantage CORTEX: LabVantage CORTEX embeds AI within laboratory execution workflows so that intelligence operates within existing scientific and compliance processes, rather than as an external layer. Hosted on Acast. See acast.com/privacy for more information.
- Apr 21, 202635 min
Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.
Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges, including higher doses, tighter control of impurities, greater batch consistency, and scalable processes to meet both clinical and commercial needs.In this GEN Podcast, two experts from SK Pharmteco, a global CMO, address these challenges and lay out some best practices that guide the manufacture of lentiviral vectors with the requisite purity, robustness, and economic feasibility required for widespread clinical adoption.Guest speakers:Mardhani Aparajithan, Director of Manufacturing, Science and Technology, SK PharmtecoTatiana Nanda, PhD, CTO, Cell and Gene Therapy, SK PharmtecoModerator:Kevin Davies, PhD, Editorial Director, GEN Hosted on Acast. See acast.com/privacy for more information.
- Apr 11, 202518 min
The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera
Sponsored by SeqeraAs data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline workflows, manage data, and scale their research. In this timely podcast, Evan Floden, CEO and co-founder of Seqera, shares how his company is addressing these needs through Nextflow—the open-source orchestrator for scalable, reproducible, and portable scientific workflows—and Seqera Platform, a unified solution for the entire scientific data lifecycle. He also discusses how Seqera has become a widely adopted solution, trusted by 13 of the top 20 pharmaceutical companies, empowering breakthroughs in drug discovery, genomics, clinical research, and.beyond. Hosted on Acast. See acast.com/privacy for more information.
- Apr 8, 20251h 0m
Smart Vector Design for Improved Cell and Gene Therapies
In the episode, we’re talking about vector design and delivery for gene therapies. The field of cell and gene therapies is advancing, but there are still challenges with delivery vectors that need to be addressed. In this podcast, experts discuss current immunogenicity hurdles, evolving DMPK strategies, and a new generation of bioanalytical tools that are contributing to the progress in the field. Hosted on Acast. See acast.com/privacy for more information.
- Apr 8, 202558 min
From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing
There are an estimated 6,000 Mendelian diseases, most of which still lack cures. Gene editing is an essential technology for studies aimed at generating data about disease-causing gene mutations and networks in order to identify optimal therapeutic targets. In this episode, experts will discuss applications of gene editing to improve scientists understanding of the relationship between variant and disease in functional genomics studies. They will also talk about the Dharmacon product suite which is designed for CRISPR-based targeted editing in a wide range of cells. Hosted on Acast. See acast.com/privacy for more information.
About GEN Podcasts
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/pri
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from GEN Podcasts in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's GEN Podcasts daily summary?
It's a free AI-powered email that summarizes new episodes of GEN Podcasts as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the GEN Podcasts podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official GEN Podcasts product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Genetic Engineering & Biotechnology News (GEN).
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does GEN Podcasts release new episodes?
GEN Podcasts publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does GEN Podcasts cover?
GEN Podcasts covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting GEN Podcasts summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.